Correlation between fibroblast growth factor receptor mutation, programmed death ligand-1 expression and survival in urinary bladder cancer based on real-world data

Background: Programmed cell death (PD)-1/PD-ligand 1 (PD-L1) inhibitors have made a breakthrough in the therapy of advanced urothelial bladder cancer (UBC). The impact of Fibroblast Growth Factor Receptor 3 (FGFR3) mutation on the effectiveness of PD-L1 treatment remains still unclear. Objective: Ou...

Full description

Bibliographic Details
Main Authors: Janos Revesz, Boglarka Posfai, Laszlo Pajor, Timea Papdan, Linda Varga, Viktor R. Paczona, Zoltan Varga, Farkas Sukosd, Aniko Maraz
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Pathology and Oncology Research
Subjects:
Online Access:https://www.por-journal.com/articles/10.3389/pore.2023.1611077/full